abstract
background
pandem
caus
sever
intern
shortag
nasopharyng
np
swab
requir
test
particip
unprecedentedli
open
urgent
iter
process
help
develop
valid
new
swab
method
test
prototyp
materi
suitabl
collect
suffici
pcr
compat
likelihood
could
massproduc
individu
packag
steril
quickli
suitabl
prototyp
select
ongo
irbapprov
clinic
trial
particip
outpati
suspect
present
drivethrough
test
station
particip
swab
control
swab
follow
prototyp
swab
prototyp
least
controlswab
posit
controlswab
neg
pcr
result
collect
measur
concord
use
cohen
kappa
compar
ct
valu
mannwhitney
u
assess
staff
prefer
via
written
survey
result
evalu
materi
design
individu
laboratori
compani
select
four
far
clinic
trial
three
complet
test
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
background
sinc
emerg
pandem
million
case
report
worldwid
result
virolog
test
remain
bottleneck
control
pandem
nasopharyng
np
swab
provid
highest
sensit
detect
infect
earli
infect
use
commerci
reversetranscriptas
polymeras
chain
reaction
rtpcr
base
assay
np
swab
fda
class
exempt
medic
devic
roughli
cm
length
diamet
design
reach
posterior
nasopharynx
fig
b
gener
consist
shaft
neck
head
coat
flock
short
synthet
filament
swab
insert
nasopharynx
rotat
collect
materi
place
vial
contain
viral
transport
media
vtm
breakpoint
shaft
enabl
detach
releas
head
vial
seal
sent
test
rapid
spread
result
sever
shortag
diagnost
test
suppli
includ
np
swab
due
manufactur
stoppag
result
decreas
suppli
pandem
spread
result
unpreced
demand
address
swab
shortag
hospit
test
center
repurpos
commerci
avail
swab
eg
throat
urogenit
collect
nasal
epitheli
mucosa
test
howev
swab
suboptim
swab
nasopharynx
due
differ
size
flexibl
possibl
contain
pcrinhibitori
materi
short
term
one
solut
design
swab
advantag
includ
simplic
multistep
process
appli
flock
widespread
avail
print
capac
abil
iter
prototyp
rapidli
resolv
swabshortag
crisi
particip
open
collabor
process
brought
togeth
mani
medic
center
individu
academ
laboratori
new
well
establish
manufactur
part
process
test
continu
provid
feedback
prototyp
swab
order
proceed
rapidli
safe
toward
develop
swab
use
clinic
volum
suffici
address
need
open
process
consciou
decis
support
substanti
bodi
scientif
literatur
includ
previou
experi
present
author
demonstr
advantag
rel
close
silo
approach
institut
process
led
ongo
clinic
trial
sever
prototyp
swab
first
result
report
preclin
evalu
phase
design
infecti
diseas
physician
clinic
microbiologist
respiratori
therapist
test
prototyp
swab
design
mechan
properti
fig
includ
size
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
collect
suffici
test
abil
collect
suffici
materi
test
use
gram
stain
swab
interior
cheek
smear
onto
standard
microscopi
slide
surrog
np
swab
comparison
gram
stain
materi
obtain
copan
diagnost
inc
mantua
itali
model
control
fig
slide
heat
fix
gram
stain
accord
bd
bbl
gram
stain
test
kit
protocol
product
consider
phase
ii
consid
stabil
autoclav
repeat
phase
test
postautoclav
materi
manufactur
shortterm
strategi
individu
packag
manufactur
state
abil
produc
least
swab
per
day
within
week
notic
consid
differ
suppli
chain
minim
risk
futur
crise
irb
field
test
phase
iii
trial
design
oversight
covidswab
adapt
trial
evalu
perform
prototyp
np
swab
prototyp
compar
copan
model
control
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
transport
bidmc
clinic
microbiolog
laboratori
sampl
test
abbott
rtpcr
platform
per
standard
clinic
protocol
statist
analys
rtpcr
result
report
categor
either
posit
neg
test
categor
concord
use
cohen
kappa
hour
qualitycontrol
data
independ
studi
test
null
hypothesi
differ
control
prototyp
swab
differ
two
control
swab
drawn
underli
distribut
p
interpret
bia
quantifi
rel
prefer
among
prototyp
gave
studi
staff
member
printout
six
possibl
pair
swab
round
robin
random
order
pair
ask
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
head
materi
fdagrad
plastic
resin
eg
keysplint
soft
head
design
evolv
sever
iter
increas
surfac
area
design
gener
featur
polygon
matrix
connect
central
taper
strut
multipl
branch
point
fig
vari
polygon
size
manufactur
abl
balanc
sampl
collect
fig
stiff
surfac
textur
variat
longitudin
central
strut
allow
vari
degre
flexibl
impact
cushion
fig
fig
staff
particip
prefer
written
staff
survey
show
prefer
prototyp
prototyp
prefer
control
swab
three
prototyp
fig
narr
feedback
prototyp
describ
less
comfort
particip
other
prototyp
describ
compar
control
fig
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
fourth
note
util
roundrobin
ab
test
survey
summar
prefer
although
narr
comment
seem
often
posit
round
robin
suggest
possibl
explan
simpli
studi
staff
familiar
control
swab
like
control
swab
prototyp
swab
test
improv
upon
manufactur
current
true
prototyp
may
test
ongo
trial
especi
crisi
perfect
enemi
good
enough
hope
experi
provid
use
case
studi
iter
produc
clinic
valid
medic
manufactur
pressur
ongo
pandem
work
other
hope
improv
continu
fight
togeth
say
goe
amaz
accomplish
care
get
credit
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
ccbynd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
